Ocular Therapeutix™ to Report Third Quarter 2014 Financial Results and Provide Business Updates on Wednesday, November 12, 2014

Ocular Therapeutix, Inc. OCUL, a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report third quarter 2014 financial results on Wednesday, November 12, 2014 at 7:00 a.m. Eastern Time. Following the announcement, the Ocular management team will host a live conference call and webcast at 8:00 a.m. Eastern Time to provide a business update and review the Company's financial results. The live webcast can be accessed by visiting Ocular's website at investors.ocutx.com. Please connect to the Company's website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. Alternatively, please call 844-464-3934 (U.S.) or 765-507-2620 (International) to listen to the conference call. The conference ID number for the live call will be 27170246. Following the webcast, an archived version of the call will be available for three months on the Company's website.